Enrica Morra

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" — Italy

Medicine · Health Sciences

59h-index15.8kcitations365works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(166), Lymphoma Diagnosis and Treatment(117), Chronic Myeloid Leukemia Treatments(92), Acute Myeloid Leukemia Research(86), Acute Lymphoblastic Leukemia research(48)

Publications365 total

Superomedial pedicle skin-reducing mastectomy in ptotic and large-sized breasts with two-stage reconstruction through transaxillary video-assisted technique: An effective surgical and anesthetic approach
Frontiers in Surgery·2023· 1 citedOpen Access
Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018
Thrombosis Research·2020· 1 cited
Transmembrane Receptors, Cytoskeleton and Cell Cycle Genes Were Progressively Deregulated in the Bone Marrow CD19+ and CD138+ Cells of Patientswwith Waldenstrom's Macroglolubinemia (WM) Vs. Subjects with IgM Monoclonal Gammopathy of Undetermined Significance Igmmgus Vs. Healthy Subjects
Blood·2019
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network
Hematological Oncology·2019· 36 cited
Jak-2 and Nfkbia Gene Expression Play a Strategic Role in Chronic Myeloid Leukemia (CML) Molecular Response during Early Nilotinib Treatment: The PhilosoPhi34 Data
Blood·2018· 2 cited
Combining Imatinib-Following-Nilotinib Treatment in First Line Therapy for Chronic Phase Chronic Myeloid Leukemia. Update from the PhilosoPhi34 Study at 24 Months of Follow-up
Blood·2018
Nilotinib Deregulates Cell Cycle Checkpoints, ABC Transporters Genes and JAK-STAT Signaling Pathway of CD34+/Lin- Cells in Chronic-Phase Chronic Myeloid Leukemia (CP-CML) Patients after 12 Months of Treatment
Blood·2018
Nilotinib induced bone marrow CD34+/lin–Ph+ cells early clearance in newly diagnosed CP‐chronic myeloid leukemia
American Journal of Hematology·2018· 5 cited
Gene Expression Profiling and Cellularity of Bone Marrow CD34+/Lin- Cells of Patients with Chronic-Phase Chronic Myeloid Leukemia at Diagnosis Vs. 12 Months of First-Line Nilotinib Treatment
Blood·2017
Preliminary Experience of Imatinib after Nilotinib in the First Line Treatment of Chronic Myeloid Leukemia
Blood·2017
Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment
Cancer Biomarkers·2017· 5 citedOpen Access
The REL-Protocol PhilosoPhi34 - an Open Label, Single Arm, Phase II Study of Nilotinib 300 Mg BID in Newly Diagnosed Chronic Phase Chronic Myeloid Leukaemia (CML) Patients - Confirms Early Clearance of Bone Marrow CD34+/Lin-Ph+ Cells
Blood·2016
Transcriptome Analysis Identified Significant Differences in Gene Expression Variability Between WM and IgM-MGUS BM B Cell Clones
Blood·2016· 1 cited
Response Assessment in Waldenström’s Macroglobulinaemia
2016
Long-Term Toxicity of Therapy in Waldenström Macroglobulinemia
2016· 2 cited
Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia
Blood·2016· 175 citedOpen Access
Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia
British Journal of Haematology·2016· 71 citedOpen Access
Clonal architecture of <i><scp>CXCR</scp>4 </i><scp>WHIM</scp>‐like mutations in Waldenström Macroglobulinaemia
British Journal of Haematology·2015· 135 cited
GEP Analyses of Bone Marrow CD34+/Lin- Cells of Chronic Phase CML Patients at Diagnosis Identified Different Sets of Genes Associated to the Molecular Response after 3 and 6 Months of First-Line Nilotinib Treatment
Blood·2015
Long Term Toxicity and Follow-up of Waldenstrom´s Macroglobulinemia Patients after Salvage Treatment with Fludarabine Cyclophosphamide Rituximab or Bendamustine and Rituximab
Blood·2015· 1 cited
page 1 of 19Next →

Frequent Co-authors

Mario Lazzarino(12), Mario Cazzola(10), Francesco Passamonti(10), Steven P. Treon(9), Giampaolo Merlini(9), Elisa Rumi(7), Cristiana Pascutto(7), Luca Arcaini(7), Pierre Morel(7), Roger G. Owen(6), Meletios Α. Dimopoulos(6), Ramón García‐Sánz(6), Alessandra Tedeschi(6), Francisco Cervantes(5), Alessandro M. Vannucchi(5), Roberto Cairoli(5), Véronique Leblond(5), Efstathios Kastritis(5), Morie A. Gertz(5), Eva Kimby(5)